Company news
Sana Biotechnology, Inc. (NASDAQ:SANA) news
Sana Biotechnology, Inc. news releases on 6ix. Latest, Sep 1, 2026: Sana Biotechnology to Present at September 2026 Investor Conferences
Press releases & updates
Sana Biotechnology to Present at September 2026 Investor Conferences
September 1, 2026
Sana Biotechnology Reports Second Quarter 2026 Financial Results and Business Updates
August 10, 2026
Sana Biotechnology Announces Follow-On Publication in The New England Journal of Medicine (NEJM) Highlighting Groundbreaking Long-Term Data and Durability of Hypoimmune-Modified Islet Cell Transplantation Without Immunosuppression in Type 1 Diabetes
July 13, 2026
Sana Biotechnology to Present at June 2026 Investor Conferences
May 27, 2026
Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility
May 15, 2026
Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs
May 12, 2026
Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates
May 10, 2026
Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference
May 5, 2026
Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting
April 27, 2026
Sana Biotechnology and Mayo Clinic Announce Strategic Collaboration Focused on Improving Care in Type 1 Diabetes and Accelerating Development of SC451
April 12, 2026
Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
March 12, 2026
Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
March 3, 2026
Sana Biotechnology to Present at March 2026 Investor Conferences
February 23, 2026
Sana Biotechnology Appoints Brian Piper as Executive Vice President, Chief Financial Officer
February 17, 2026
Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 7, 2026
Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform
December 7, 2025
Sana Biotechnology to Present at December 2025 Investor Conferences
November 23, 2025
Sana Biotechnology Reports Third Quarter 2025 Financial Results and Business Updates
November 5, 2025
Sana Biotechnology to Present at the TD Cowen Immunology & Inflammation Summit
November 3, 2025
Yellowstone Biosciences Appoints James ("Jim") MacDonald as Chief Executive Officer
September 16, 2025
Sana Biotechnology to Present at September 2025 Investor Conferences
August 25, 2025
Sana Biotechnology Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares
August 19, 2025
eGenesis Appoints Douglas Williams, Ph.D., and Adam Craig, M.D., Ph.D., to its Board of Directors
August 19, 2025
Sana Biotechnology Reports Second Quarter 2025 Financial Results and Business Updates
August 10, 2025
Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
August 5, 2025
Sana Biotechnology Announces Pricing of Public Offering
August 5, 2025
Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes
August 3, 2025
Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
June 22, 2025
Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions
June 8, 2025
Sana Biotechnology to Present at June 2025 Investor Conferences
May 27, 2025
Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference
May 11, 2025
Sana Biotechnology Reports First Quarter 2025 Financial Results and Business Updates
May 7, 2025
Flagship Pioneering, the National University of Singapore, National University Hospital and the National University Health System Announce Collaboration to Advance Biotech Research & Development
May 6, 2025
Sana Biotechnology Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
March 16, 2025
Sana Biotechnology to Present at the Cowen 45th Annual Health Care Conference
February 23, 2025
Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 7, 2025
Sana Biotechnology Announces Positive Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
January 6, 2025
Sana Biotechnology Announces Fast Track Designation for SC291 in Relapsed/Refractory Systemic Lupus Erythematosus
December 1, 2024
Sana Biotechnology to Present at December 2024 Investor Conferences
November 24, 2024
Sana Biotechnology Reports Third Quarter 2024 Financial Results and Business Updates
November 7, 2024
Sana Biotechnology Announces Increased Focus on Type 1 Diabetes and B-cell Mediated Autoimmune Diseases with the Potential to Deliver Clinical Proof of Concept Data Across Multiple Studies in 2024 and 2025
November 3, 2024
Sana Biotechnology to Present at the Goldman Sachs Cell Therapy Day Conference
September 29, 2024
Sana Biotechnology to Present at September 2024 Investor Conferences
August 28, 2024
Sana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice President and Chief Scientific Officer
August 25, 2024
Sana Biotechnology Reports Second Quarter 2024 Financial Results and Business Updates
August 7, 2024
Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data Showing the Potential for Pluripotent Stem Cell-Derived Human Glial Progenitor Cell Transplantation as a Treatment for Huntington’s Disease and Other G...
May 20, 2024
Sana Biotechnology Reports First Quarter 2024 Financial Results and Business Updates
May 7, 2024
Sana Biotechnology to Present at May and June 2024 Investor Conferences
May 5, 2024
Sana Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
February 28, 2024
Sana Biotechnology to Present at the Cowen 44th Annual Health Care Conference
February 27, 2024